Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 2 , Pages 183-192, April 2010

Adverse effects of drugs in the treatment of viral hepatitis

  • Francesco Negro (Professor)

      Affiliations

    • Divisions of Clinical Pathology, University Hospitals, 24 rue Micheli-du-Crest, 1211 Geneva 14, Switzerland
    • Divisions of Gastroenterology and Hepatology, University Hospitals, 4 rue Gabrielle-Perret-Gentil, 1211 Geneva 14, Switzerland
    • Corresponding Author InformationDivision of Clinical Pathology, Centre Médical Universitaire, 1 rue Michel-Servet, 1206 Geneva, Switzerland. Tel.: +41 22 3795800; fax: +41 22 3729366.

The hepatitis B virus (HBV) and the hepatitis C virus (HCV) affect approximately 400–500 million individuals worldwide. Both infections are characterised by a significant morbidity and mortality: chronic hepatitis B and C may evolve towards the development of cirrhosis and primary hepatocellular carcinoma. During the last two decades, several new antivirals have been developed that are active against HBV and HCV, allowing sustained cure rates in a significant proportion of patients. All these drugs have side effects, which may represent a major barrier to achieve cure in many patients in need. I will review the most common adverse events reported during the therapy of chronic hepatitis B and C, with some recommendations for proper management.

Keywords: Hepatitis B virus, Hepatitis C virus, Interferon-α, Side effects, Barriers to treatment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6918(09)00161-9

doi:10.1016/j.bpg.2009.10.012

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 2 , Pages 183-192, April 2010

Article Tools